Please note that the account you create here is different than your Keystone Symposia account at www.keystonesymposia.org used to register for our multi-day conferences and is uniquely for viewing our virtual content.
The Genome Editing Revolution: Translating Genome Editing Technologies into Human Therapies
Recent advances in genome editing nucleases have led to their broader application in biomedical research and dramatically accelerated efforts to develop therapeutics based on this technology. In this dynamic, interactive panel event, experts in genome editing and gene therapy from academia and industry will discuss the following topics and others relevant to clinical translation of the technology:
What are the most important recent basic science and technological advances and biggest impacts in the field of genome editing that will substantially advance the prospects of gene-based therapy?
How can the experiences of the gene therapy field inform the development of genome editing therapeutics?
What are the risks and biggest obstacles that must be minimized and overcome to successfully translate genome editing into human therapeutics?
Which diseases are the most promising candidates to benefit from genome editing therapies?
What impact, if any, has the CRISPR IP dispute had on developing gene-based therapeutics?
Copyright Keystone Symposia, 2017. All rights reserved.
About Keystone Symposia:
Keystone Symposia is a 501(c)(3) nonprofit organization founded in 1972 that convenes 50-60 open, international scientific research conferences each year across the full range of the life sciences – from cardiovascular disease to immunology to neurobiology. The conferences accelerate life science discovery by bringing together and fostering collaboration among the world’s leading and next generation of research scientists.